4 ms·
But you've just open sourced their entire value-proposition, which is that correlation part based on all the data. Mapping your DNA is now the 'easy' part, and
by LogicX 13y ago
But you've just open sourced their entire value-proposition, which is that correlation part based on all the data. Mapping your DNA is now the 'easy' part, and offers them no differentiation and competitive advantage. (Ok, they still have lots of data to use to do their own lookups of all customers using the FOSS and improve that project, but again, they're adding value outside their company)
- derefr 13y agoI think that could still be tenable, if the marketing was rearranged so that the FOSS project was the initial point-of-contact for people looking for gene mapping (picture it as a whole app, rather than just an extension), and then it does lead-gen for "23andMe, the premium gene mapping service compatible with our gene explorer." The FOSS project still might get forked, of course... but as long as the 23andMe people are actually the leading experts in doing those correlational studies, their fork will stay the canonical/preferred one. Seems more honest. (Of course, no company wants to have to be "honest" in that way, but if the only other option being legislated out of existence, it might still be a profitable strategy.)